NCT02654080 · Interventional trial
Evaluating the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy, HIV-Uninfected Adults
Overall registry status Completed
Phase 1
Conditions HIV Infections
Delaware Valley sites
- Penn Prevention CRS · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory